Interestingly, expression data from immune ROIs indicated that the presence of EpCAM and cytokeratin was associated with better patient OS (Figure 8), while the presence of CD34, CD3, and ICOS in tumour ROIs was associated with better patient OS. This evidence concerns the gene CD34 and neoplasm.